Safety and tolerability of intranasal insulin in Parkinson’s disease
Background Repurposing therapeutic treatments for diabetes may be a promising strategy for the treatment of neurodegenerative disorders. Intranasal insulin (INI) is shown to improve memory, attention, and cognition in Alzheimer’s dementia. Associations between the etiology of Parkinson’s Disease (PD), brain glucose hyp...